IBRX
ImmunityBio Inc.
Latest News for IBRX
There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Mediwound (MDWD) and ImmunityBio (IBRX) with bullish......
ImmunityBio ( ($IBRX) ) just unveiled an update. On April 6, 2026, ImmunityBio, Inc. announced it had submitted a comprehensive response to a March......
Insiders have been trading these 5 stocks: (($IBRX)), (($KEYS)), (($RBRK)), (($AFL)) and (($MCO)). Here is a breakdown of their recent trades and t......
Executive Accountability: Patrick Soon-Shiong Named in Securities Action NEW YORK, March 31, 2026 — Levi & Korsinsky, LLP notifies investors that D......
ImmunityBio (IBRX) is facing a securities lawsuit after investors alleged that public statements about Anktiva overstated its capabilities, includi......
ImmunityBio ($IBRX) shares dropped over 26% on Tuesday after the U.S. Food and Drug Administration (FDA) issued a warning letter to the biotechnolo......
News data is sourced from MarketXLS API and updated regularly.
Showing 6 of 6 articles.
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | IBRX | $7.48 | +7.2% | 21.51M |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |